Brief: Microba Life Sciences Says Q2 FY26 Total Revenue A$3.7M
29/01/2026 01:19
Jan 29 (Reuters) - Microba Life Sciences MAP.AX: Q2 FY26 TOTAL REVENUE A$3.7M Further company coverage: MAP.AX ((Reuters.Briefs@thomsonreuters.com;))
Recent news on Microba Life Sciences
See all newsBrief: Genetic Signatures Says Microba Shareholders To Hold 60% Of GSS On Merger
Brief: Microba Life Sciences Announces Placement Via Two Tranches
Brief: Microba Life Sciences Appoints Geoffrey Cockerill As Interim CEO
Australia's Genetic Signatures climbs on potential merger with Microba
Brief: Microba Life Sciences Says Microba Signs Multi-Year Synlab Agreement